TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITEDTIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITEDTIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

No trades
See on Supercharts

600329 fundamentals

An in-depth look to TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED operating, investing, and financing activities

600329 free cash flow for Q1 24 is 67.12 M CNY. For 2023, 600329 free cash flow was 725.74 M CNY and operating cash flow was 866.67 M CNY.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Free cash flowYoY growth